Anemia, a condition characterized by a decrease in the total amount of red blood cells or hemoglobin in the blood, is a common but complex clinical issue. The diagnosis of anemia requires a systematic approach due to the myriad underlying causes and the wide range of potential presentations.
The initial evaluation of a patient suspected to have anemia should include a thorough history and physical examination. This will often provide clues to the etiology of the anemia. The initial laboratory evaluation should include a complete blood count, reticulocyte count, and peripheral smear.
Anemias can be broadly classified into three groups based on the mean corpuscular volume: microcytic, normocytic, and macrocytic. Each group has a distinct set of potential etiologies that must be considered. For example, microcytic anemia is often due to iron deficiency or thalassemia, while macrocytic anemia may be due to vitamin B12 or folate deficiency.
Further diagnostic testing should be guided by the initial evaluation and classification. For example, in a patient with suspected iron deficiency anemia, serum iron studies may be indicated. In a patient with suspected hemolytic anemia, tests such as haptoglobin, lactate dehydrogenase, and direct antiglobulin test may be useful.
The management of anemia should be tailored to the underlying cause. For example, iron deficiency anemia may be managed with oral iron supplementation, while vitamin B12 deficiency may require parenteral therapy. Follow-up is crucial to ensure response to therapy and to monitor for potential complications.
Anemia is a complex clinical issue that requires a systematic diagnostic approach. By understanding the classification and potential etiologies of anemia, and by utilizing appropriate diagnostic testing, healthcare providers can effectively diagnose and manage this common condition.
1.
Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety
2.
As EGFR internalization is decreased, BUB1 controls EGFR signaling.
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
Low Income, Education Tied to Depression in Older Adults
5.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
1.
Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care
2.
Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies
3.
Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine
4.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
5.
Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
4.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
5.
Navigating the Complexities of Ph Negative ALL - Part XV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation